MENU
ANNX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Annexon (ANNX) Ownership - Who owns Annexon?
Profile
Industry
N/A
Address
1400 Sierra Point Parkway
Phone
+1 650 822-5500
Employees
71
Web
https://www.annexonbio.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
560.68M
P/E Ratio
N/A
Total Cash
340.12M
Projected Growth
N/A
Total Debt
29.61M
Revenue
N/A
Risk (Beta)
1.33
Dividend Yield
N/A
Total Cash/Share
3.19
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
ANNX
Capitalization
561M
P/E Ratio
N/A
Risk (Beta)
1.33
Dividend Yield
N/A
Total Cash
340M
Total Cash/Share
3.19
Total Debt
29.6M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
332M
P/B Ratio
1.70
Cash Flow
N/A
Earnings
-1.03
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
106K
Current Ratio
17.18
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-129.45M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-40.34
Shares Held By Institutions
923M
Shares Outstanding - Current
107M
Total Liabilities
47.2M
Total Volume MTD
N/A
Value
1
Gain YTD
16.300
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a clinical-stage biopharmaceutical company, which develops a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, eye and brain
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
1400 Sierra Point Parkway
Phone
+1 650 822-5500
Employees
71
Web
https://www.annexonbio.com